These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
336 related items for PubMed ID: 15121020
1. Efficacy and safety of ibandronate given by intravenous injection once every 3 months. Adami S, Felsenberg D, Christiansen C, Robinson J, Lorenc RS, Mahoney P, Coutant K, Schimmer RC, Delmas PD. Bone; 2004 May; 34(5):881-9. PubMed ID: 15121020 [Abstract] [Full Text] [Related]
2. Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis. Recker R, Stakkestad JA, Chesnut CH, Christiansen C, Skag A, Hoiseth A, Ettinger M, Mahoney P, Schimmer RC, Delmas PD. Bone; 2004 May; 34(5):890-9. PubMed ID: 15121021 [Abstract] [Full Text] [Related]
7. Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis. Thiébaud D, Burckhardt P, Kriegbaum H, Huss H, Mulder H, Juttmann JR, Schöter KH. Am J Med; 1997 Oct; 103(4):298-307. PubMed ID: 9382122 [Abstract] [Full Text] [Related]
8. Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study. Eisman JA, Civitelli R, Adami S, Czerwinski E, Recknor C, Prince R, Reginster JY, Zaidi M, Felsenberg D, Hughes C, Mairon N, Masanauskaite D, Reid DM, Delmas PD, Recker RR. J Rheumatol; 2008 Mar; 35(3):488-97. PubMed ID: 18260172 [Abstract] [Full Text] [Related]
9. Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women. Stakkestad JA, Benevolenskaya LI, Stepan JJ, Skag A, Nordby A, Oefjord E, Burdeska A, Jonkanski I, Mahoney P, Ibandronate Intravenous Study Group. Ann Rheum Dis; 2003 Oct; 62(10):969-75. PubMed ID: 12972476 [Abstract] [Full Text] [Related]
13. Effect of daily and intermittent use of ibandronate on bone mass and bone turnover in postmenopausal osteoporosis: a review of three phase II studies. Schimmer RC, Bauss F. Clin Ther; 2003 Jan; 25(1):19-34. PubMed ID: 12637110 [Abstract] [Full Text] [Related]